The two major vaccine manufacturing countries are China and Russia. Vaccines require regulatory approval from SAHPRA. Countries cannot be the applicant and have to work through commercial entities to obtain approval. We have been in discussion with a number of companies having obtained marketing approval from the Gamaleya Institute of Russia for the Sputnik vaccine and with Numolux for the Sinovac vaccine. When all regulatory mattera have been attended to, the negotiations will progress further.
END.